HK Stock MarketDetailed Quotes

01681 CONSUN PHARMA

Watchlist
  • 5.690
  • +0.060+1.07%
Trading Apr 25 14:39 CST
4.62BMarket Cap5.34P/E (TTM)

CONSUN PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
10.71%2.59B
12.70%1.12B
14.43%2.34B
12.07%993.53M
16.65%2.04B
15.76%886.53M
1.42%1.75B
-18.62%765.86M
-6.28%1.73B
8.29%941.04M
Operating income
10.71%2.59B
12.70%1.12B
14.43%2.34B
12.07%993.53M
16.65%2.04B
15.76%886.53M
1.42%1.75B
-18.62%765.86M
-6.28%1.73B
8.29%941.04M
Cost of sales
-15.90%-668.44M
-10.89%-283.26M
-11.48%-576.74M
-13.38%-255.44M
-19.98%-517.32M
-15.97%-225.29M
7.65%-431.16M
23.49%-194.27M
-1.59%-466.85M
-17.01%-253.89M
Operating expenses
-15.90%-668.44M
-10.89%-283.26M
-11.48%-576.74M
-13.38%-255.44M
-19.98%-517.32M
-15.97%-225.29M
7.65%-431.16M
23.49%-194.27M
-1.59%-466.85M
-17.01%-253.89M
Gross profit
9.01%1.92B
13.32%836.42M
15.42%1.76B
11.62%738.09M
15.56%1.53B
15.68%661.24M
4.78%1.32B
-16.82%571.59M
-8.89%1.26B
5.38%687.14M
Selling expenses
-10.40%-852.21M
-10.57%-362.03M
-24.50%-771.96M
-18.28%-327.42M
-14.20%-620.04M
-23.55%-276.81M
-0.69%-542.93M
18.32%-224.04M
3.98%-539.2M
-0.27%-274.28M
Administrative expenses
2.14%-315.6M
-1.07%-136.74M
-15.20%-322.5M
-31.87%-135.3M
-37.86%-279.96M
-16.87%-102.6M
-25.75%-203.07M
-8.66%-87.79M
8.52%-161.49M
-6.63%-80.79M
Impairment and provision
-61.23%12.6M
37.08%17.53M
80.09%32.49M
850.22%12.79M
161.45%18.04M
109.28%1.35M
92.59%-29.36M
-48.67%-14.51M
---396.48M
---9.76M
-Goodwill impairment
----
----
----
----
----
----
----
----
---326.14M
----
-Other impairment is provision
-61.23%12.6M
37.08%17.53M
80.09%32.49M
850.22%12.79M
161.45%18.04M
109.28%1.35M
58.26%-29.36M
-48.67%-14.51M
---70.35M
---9.76M
Special items of operating profit
110.16%118.5M
16.44%29.63M
-11.04%56.39M
-14.47%25.45M
7.75%63.38M
144.70%29.76M
3,954.91%58.83M
1,489.83%12.16M
30.45%-1.53M
-115.08%-875K
Operating profit
16.85%884.97M
22.70%384.81M
6.85%757.33M
0.22%313.61M
17.12%708.77M
21.57%312.93M
271.92%605.14M
-19.92%257.41M
-74.74%162.71M
4.18%321.44M
Financing cost
-94.49%-21.26M
-76.04%-7.21M
15.28%-10.93M
21.89%-4.09M
39.70%-12.91M
54.40%-5.24M
26.31%-21.4M
0.23%-11.49M
-5.73%-29.04M
20.07%-11.52M
Earning before tax
15.72%863.7M
22.00%377.61M
7.26%746.39M
0.59%309.52M
19.21%695.86M
25.12%307.69M
336.72%583.74M
-20.65%245.92M
-78.33%133.66M
5.37%309.92M
Tax
-23.05%-77.15M
-114.56%-29.78M
42.35%-62.7M
77.90%-13.88M
-6.62%-108.74M
-28.91%-62.79M
-44.59%-101.99M
2.55%-48.7M
40.83%-70.54M
15.00%-49.98M
After-tax profit from continuing operations
15.04%786.55M
17.65%347.83M
16.45%683.7M
20.72%295.64M
21.87%587.12M
24.18%244.91M
663.19%481.74M
-24.13%197.21M
-87.31%63.12M
10.46%259.94M
Earning after tax
15.04%786.55M
17.65%347.83M
16.45%683.7M
20.72%295.64M
21.87%587.12M
24.18%244.91M
663.19%481.74M
-24.13%197.21M
-87.31%63.12M
10.46%259.94M
Minority profit
155.70%2.02M
94.12%-64K
125.86%790K
81.02%-1.09M
82.08%-3.06M
50.84%-5.74M
-2.08%-17.05M
-211.44%-11.67M
-151.96%-16.7M
-35.79%10.47M
Profit attributable to shareholders
14.88%784.53M
17.24%347.89M
15.71%682.91M
18.39%296.73M
18.32%590.17M
19.99%250.64M
524.89%498.79M
-16.27%208.89M
-82.85%79.82M
13.91%249.47M
Basic earnings per share
15.12%0.99
17.77%0.4408
16.22%0.86
19.51%0.3743
21.31%0.74
23.94%0.3132
577.78%0.61
-13.72%0.2527
-83.47%0.09
14.24%0.2929
Diluted earnings per share
13.95%0.98
16.98%0.4367
17.81%0.86
19.76%0.3733
19.67%0.73
23.35%0.3117
577.78%0.61
-12.01%0.2527
-83.02%0.09
15.06%0.2872
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 10.71%2.59B12.70%1.12B14.43%2.34B12.07%993.53M16.65%2.04B15.76%886.53M1.42%1.75B-18.62%765.86M-6.28%1.73B8.29%941.04M
Operating income 10.71%2.59B12.70%1.12B14.43%2.34B12.07%993.53M16.65%2.04B15.76%886.53M1.42%1.75B-18.62%765.86M-6.28%1.73B8.29%941.04M
Cost of sales -15.90%-668.44M-10.89%-283.26M-11.48%-576.74M-13.38%-255.44M-19.98%-517.32M-15.97%-225.29M7.65%-431.16M23.49%-194.27M-1.59%-466.85M-17.01%-253.89M
Operating expenses -15.90%-668.44M-10.89%-283.26M-11.48%-576.74M-13.38%-255.44M-19.98%-517.32M-15.97%-225.29M7.65%-431.16M23.49%-194.27M-1.59%-466.85M-17.01%-253.89M
Gross profit 9.01%1.92B13.32%836.42M15.42%1.76B11.62%738.09M15.56%1.53B15.68%661.24M4.78%1.32B-16.82%571.59M-8.89%1.26B5.38%687.14M
Selling expenses -10.40%-852.21M-10.57%-362.03M-24.50%-771.96M-18.28%-327.42M-14.20%-620.04M-23.55%-276.81M-0.69%-542.93M18.32%-224.04M3.98%-539.2M-0.27%-274.28M
Administrative expenses 2.14%-315.6M-1.07%-136.74M-15.20%-322.5M-31.87%-135.3M-37.86%-279.96M-16.87%-102.6M-25.75%-203.07M-8.66%-87.79M8.52%-161.49M-6.63%-80.79M
Impairment and provision -61.23%12.6M37.08%17.53M80.09%32.49M850.22%12.79M161.45%18.04M109.28%1.35M92.59%-29.36M-48.67%-14.51M---396.48M---9.76M
-Goodwill impairment -----------------------------------326.14M----
-Other impairment is provision -61.23%12.6M37.08%17.53M80.09%32.49M850.22%12.79M161.45%18.04M109.28%1.35M58.26%-29.36M-48.67%-14.51M---70.35M---9.76M
Special items of operating profit 110.16%118.5M16.44%29.63M-11.04%56.39M-14.47%25.45M7.75%63.38M144.70%29.76M3,954.91%58.83M1,489.83%12.16M30.45%-1.53M-115.08%-875K
Operating profit 16.85%884.97M22.70%384.81M6.85%757.33M0.22%313.61M17.12%708.77M21.57%312.93M271.92%605.14M-19.92%257.41M-74.74%162.71M4.18%321.44M
Financing cost -94.49%-21.26M-76.04%-7.21M15.28%-10.93M21.89%-4.09M39.70%-12.91M54.40%-5.24M26.31%-21.4M0.23%-11.49M-5.73%-29.04M20.07%-11.52M
Earning before tax 15.72%863.7M22.00%377.61M7.26%746.39M0.59%309.52M19.21%695.86M25.12%307.69M336.72%583.74M-20.65%245.92M-78.33%133.66M5.37%309.92M
Tax -23.05%-77.15M-114.56%-29.78M42.35%-62.7M77.90%-13.88M-6.62%-108.74M-28.91%-62.79M-44.59%-101.99M2.55%-48.7M40.83%-70.54M15.00%-49.98M
After-tax profit from continuing operations 15.04%786.55M17.65%347.83M16.45%683.7M20.72%295.64M21.87%587.12M24.18%244.91M663.19%481.74M-24.13%197.21M-87.31%63.12M10.46%259.94M
Earning after tax 15.04%786.55M17.65%347.83M16.45%683.7M20.72%295.64M21.87%587.12M24.18%244.91M663.19%481.74M-24.13%197.21M-87.31%63.12M10.46%259.94M
Minority profit 155.70%2.02M94.12%-64K125.86%790K81.02%-1.09M82.08%-3.06M50.84%-5.74M-2.08%-17.05M-211.44%-11.67M-151.96%-16.7M-35.79%10.47M
Profit attributable to shareholders 14.88%784.53M17.24%347.89M15.71%682.91M18.39%296.73M18.32%590.17M19.99%250.64M524.89%498.79M-16.27%208.89M-82.85%79.82M13.91%249.47M
Basic earnings per share 15.12%0.9917.77%0.440816.22%0.8619.51%0.374321.31%0.7423.94%0.3132577.78%0.61-13.72%0.2527-83.47%0.0914.24%0.2929
Diluted earnings per share 13.95%0.9816.98%0.436717.81%0.8619.76%0.373319.67%0.7323.35%0.3117577.78%0.61-12.01%0.2527-83.02%0.0915.06%0.2872
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor KPMG--KPMG--KPMG--KPMG--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg